Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

Tyler Fletcher called up to replace injured Billy Gilmour

Scotland have been forced into a late change to their World Cup squad after Billy Gilmour was ruled out through injury, with ...
The Daily Tribune News

Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival data from ...